TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 9.409
AS - Asia 4.920
EU - Europa 2.258
SA - Sud America 810
AF - Africa 712
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 67
Totale 18.245
Nazione #
US - Stati Uniti d'America 8.927
SG - Singapore 1.527
CN - Cina 994
HK - Hong Kong 648
IT - Italia 551
VN - Vietnam 530
BR - Brasile 518
FI - Finlandia 206
DE - Germania 200
FR - Francia 183
BD - Bangladesh 176
SE - Svezia 162
IN - India 148
PL - Polonia 129
CA - Canada 113
GB - Regno Unito 99
RU - Federazione Russa 87
IQ - Iraq 69
JP - Giappone 69
NL - Olanda 67
PH - Filippine 66
AR - Argentina 58
TR - Turchia 56
MX - Messico 44
PK - Pakistan 43
AT - Austria 42
UA - Ucraina 41
ZA - Sudafrica 40
EC - Ecuador 38
JO - Giordania 37
KR - Corea 35
CO - Colombia 34
ES - Italia 34
PE - Perù 34
PY - Paraguay 33
SA - Arabia Saudita 32
UZ - Uzbekistan 32
JM - Giamaica 30
IE - Irlanda 29
EG - Egitto 28
ID - Indonesia 28
NI - Nicaragua 28
VE - Venezuela 27
CY - Cipro 26
MA - Marocco 26
CR - Costa Rica 25
EE - Estonia 25
LB - Libano 25
MY - Malesia 25
TH - Thailandia 25
AE - Emirati Arabi Uniti 24
AZ - Azerbaigian 24
HN - Honduras 24
TW - Taiwan 24
BF - Burkina Faso 23
CM - Camerun 23
GR - Grecia 23
LC - Santa Lucia 23
PS - Palestinian Territory 23
RO - Romania 23
CD - Congo 22
CG - Congo 22
IL - Israele 22
LA - Repubblica Popolare Democratica del Laos 22
BY - Bielorussia 21
CL - Cile 21
LV - Lettonia 21
SD - Sudan 21
CZ - Repubblica Ceca 20
ET - Etiopia 20
KZ - Kazakistan 20
LY - Libia 20
MN - Mongolia 20
MR - Mauritania 20
PA - Panama 20
TN - Tunisia 20
AL - Albania 19
AO - Angola 19
BG - Bulgaria 19
MG - Madagascar 19
MU - Mauritius 19
PT - Portogallo 19
AD - Andorra 18
AM - Armenia 18
BZ - Belize 18
CI - Costa d'Avorio 18
GA - Gabon 18
GN - Guinea 18
KE - Kenya 18
KG - Kirghizistan 18
ML - Mali 18
SK - Slovacchia (Repubblica Slovacca) 18
SN - Senegal 18
CH - Svizzera 17
GH - Ghana 17
IR - Iran 17
NO - Norvegia 17
TJ - Tagikistan 17
UY - Uruguay 17
BB - Barbados 16
Totale 17.445
Città #
Ashburn 984
San Jose 983
Singapore 916
Fairfield 864
Woodbridge 596
Hong Kong 569
Chandler 465
Ann Arbor 439
Houston 409
Wilmington 349
Seattle 302
Cambridge 280
Jacksonville 259
Council Bluffs 250
Santa Clara 201
Beijing 182
Los Angeles 180
Ho Chi Minh City 158
Boardman 156
Hanoi 143
Princeton 110
San Diego 101
Bytom 97
Helsinki 96
Medford 96
Lauterbourg 89
Padova 87
Nanjing 86
Des Moines 83
Dearborn 69
New York 64
Guangzhou 57
Roxbury 55
São Paulo 49
Milan 46
Chicago 38
Tokyo 37
Dallas 36
Munich 36
Buffalo 35
Changsha 35
Amman 34
Shenyang 33
Rome 29
Jinan 28
Johannesburg 27
Orem 27
Baghdad 26
Haiphong 26
Hefei 26
Montreal 26
Managua 25
Tashkent 25
Brooklyn 24
Da Nang 24
Lima 24
London 24
Nanchang 24
Baku 23
Dublin 23
Frankfurt am Main 23
Rio de Janeiro 23
Castries 22
Hebei 22
San José 21
Warsaw 21
Kinshasa 20
Kunming 20
Lahore 20
Nouakchott 20
Panama City 20
Antananarivo 19
Jiaxing 19
Pune 19
Riga 19
Ulan Bator 19
Vienna 19
Vientiane 19
Abidjan 18
Andorra la Vella 18
Atlanta 18
Libreville 18
Nairobi 18
Nuremberg 18
Amsterdam 17
Bamako 17
Conakry 17
Kingston 17
Minsk 17
Shanghai 17
Accra 16
Addis Ababa 16
Bishkek 16
Brasília 16
Dakar 16
Dushanbe 16
Luanda 16
Lusaka 16
Ouagadougou 16
Turku 16
Totale 11.320
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 403
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 378
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 334
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 315
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 293
Implicazioni biologiche di SerpinB3 nella fibrosi epatica e nell'epatocarcinoma 292
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 284
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 282
SERPINB3 induces epithelial-mesenchymal transition. 275
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 272
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 267
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 266
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 264
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 260
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 257
Correction: Corrigendum: SERPINB3 is associated with longer survival in transgenic mice 256
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 255
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 255
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 249
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 248
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 246
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 243
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 240
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 238
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 236
Prone Positioning Is Safe and May Reduce the Rate of Intubation in Selected COVID-19 Patients Receiving High-Flow Nasal Oxygen Therapy 236
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 235
Hepatic progenitor cells express SerpinB3 230
Serpinb3 is overexpressed in the liver in presence of iron overload 229
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 228
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 225
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 223
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 221
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 220
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 212
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 208
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 204
SERPINB3 is associated with longer survival in transgenic mice. 199
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I. 186
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 186
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 185
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 179
Hepatic progenitor cells express SerpinB3. 179
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 173
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 171
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 170
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 166
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 164
SERPINB3 modulates TGF-beta expression in chronic liver disease. 163
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 161
Role of microglial activation via SERPINB3 in experimental acute hepatic encephalopathy 159
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 154
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 153
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 152
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 150
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 150
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 145
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 145
Liver pro-oncogenic potential of SERPINB3. 145
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 144
SERPIN-B3 induces HIF2α nuclear translocation in hepatic cancer cells: a paracrine loop able to affect cancer cell behaviour 143
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 140
MicroRNAs and SerpinB3 in hepatocellular carcinoma. 139
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 136
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 136
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 134
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 130
SERPINB3 è associata a una maggior sopravvivenza in un modello di topo transgenico. 129
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 129
SERPINB3 IS OVEREXPRESSED IN HEPATOBLASTOMA AND CORRELATES WITH MYC SIGNALING AND ANATOMIC TUMOR INVASION 126
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 124
LRP-1 BINDS SERPINB3 AND MEDIATES ITS MIGRATORY ACTIVITY 123
HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY 122
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 121
SERPIN-B3 as a pro-fibrogenic mediator contributing to chronic liver disease progression 121
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 119
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 119
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 118
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 116
Caratterizzazione biologica e funzionale della nuova isoforma SCCA-PD 116
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 113
MODULAZIONE DI P53 E DELLE SUE VIE DI SEGNALE DA PARTE DI SERPINB3 113
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumor? 113
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 111
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 111
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 110
RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA 109
SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis. 107
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 106
SERPINB3 IS ASSOCIATED TO LONGER SERVIVAL IN MALE TRANSGENIC MICE 106
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 106
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 104
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 103
SERPINB3 DOWNREGULATES THE PROAPOPTOTIC P66SHC PROTEIN IN HUMAN HEPATOMA CELLS 103
SERPINB3 IS ASSOCIATED TO LONGHER SURVIVAL IN MALE TRANSGENIC MICE 101
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 100
SerpinB3 drives molecular signatures of worse prognosis and is associated with tumor recurrence in hepatocellular carcinoma 100
ONCOSTATIN M IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND CAN INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HEPATIC CANCER CELLS BY TWO DISTINCT MECHANISMS 96
P66SHC EXPRESSION PROTEIN IS DOWNREGULATED BY SERPINB3 IN HUMAN HEPATOMA CELLS 95
ONCOSTATIN M, OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA, UP-REGULATES SERPIN-B3 EXPRESSION IN HEPATIC CANCER CELLS 91
Totale 17.997
Categoria #
all - tutte 50.753
article - articoli 38.796
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022792 0 0 0 98 33 68 44 128 37 32 102 250
2022/20231.012 191 93 42 97 173 157 1 75 125 2 43 13
2023/2024495 28 69 63 50 26 70 35 14 17 18 43 62
2024/20252.167 11 128 67 91 245 79 117 180 171 85 446 547
2025/20268.126 328 811 1.033 1.070 707 331 1.256 687 844 458 408 193
2026/20271.214 268 387 336 223 0 0 0 0 0 0 0 0
Totale 18.245